Borchmann P - Search Results

1

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German Hodgkin Study Group.

Engert A, Goergen H, Markova J, Pabst T, Meissner J, Zijlstra JM, Král Z, Eichenauer DA, Soekler M, Greil R, Kreissl S, Scheuvens R, Eich H, Kobe C, Dietlein M, Stein H, Fuchs M, Diehl V, Borchmann P. Engert A, et al. Among authors: borchmann p. Hemasphere. 2017 Dec 20;1(1):e5. doi: 10.1097/HS9.0000000000000005. eCollection 2017 Dec. Hemasphere. 2017. PMID: 31723734 Free PMC article.

2

[Chronic lymphatic leukemia. Progress in diagnosis and therapy].

Borchmann P, Diehl V, Engert A. Borchmann P, et al. Internist (Berl). 1996 Oct;37(10):1022-9. Internist (Berl). 1996. PMID: 9019446 Review. German. No abstract available.

3

A phase I/II study of idarubicin, dexamethasone and interferon-alpha (I-Dexa) in patients with relapsed or refractory multiple myeloma.

Hübel K, Tesch H, Kröger B, Schnell R, Borchmann P, Diehl V, Engert A. Hübel K, et al. Among authors: borchmann p. Leukemia. 1997 Dec;11 Suppl 5:S47-51. Leukemia. 1997. PMID: 9436939 Clinical Trial.

4

DIZE (dexamethasone, idarubicin, and continuous infusion of ifosfamide and etoposide): an effective and well-tolerated new regimen for patients with relapsed lymphoma.

Reiser M, Schnell R, Straub G, Borchmann P, Wilhelm M, Ubelacker R, Wörmann B, Münch R, Diehl V, Engert A. Reiser M, et al. Among authors: borchmann p. Leuk Lymphoma. 1998 Oct;31(3-4):359-66. doi: 10.3109/10428199809059229. Leuk Lymphoma. 1998. PMID: 9869200 Clinical Trial.

5

New drugs in the treatment of Hodgkin's disease.

Borchmann P, Schnell R, Diehl V, Engert A. Borchmann P, et al. Ann Oncol. 1998;9 Suppl 5:S103-8. doi: 10.1093/annonc/9.suppl_5.s103. Ann Oncol. 1998. PMID: 9926247 Review.

6

Development of IgG lambda multiple myeloma in a patient with cutaneous CD30+ anaplastic T-cell lymphoma.

Wickenhauser C, Borchmann P, Diehl V, Scharffetter-Kochanek K. Wickenhauser C, et al. Among authors: borchmann p. Leuk Lymphoma. 1999 Sep;35(1-2):201-6. doi: 10.3109/10428199909145720. Leuk Lymphoma. 1999. PMID: 10512178

7

Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin's lymphoma.

Borchmann P, Schnell R, Knippertz R, Staak JO, Camboni GM, Bernareggi A, Hübel K, Staib P, Schulz A, Diehl V, Engert A. Borchmann P, et al. Ann Oncol. 2001 May;12(5):661-7. doi: 10.1023/a:1011139016294. Ann Oncol. 2001. PMID: 11432625 Free article. Clinical Trial.

8

Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia.

Pfitzner T, Reiser M, Barth S, Borchmann P, Schulz H, Schinköthe T, Oberhäuser F, Wessels J, Tur M, Diehl V, Engert A. Pfitzner T, et al. Among authors: borchmann p. Ann Hematol. 2002 May;81(5):258-66. doi: 10.1007/s00277-002-0449-4. Epub 2002 Apr 9. Ann Hematol. 2002. PMID: 12029535

9

A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma.

Schnell R, Staak O, Borchmann P, Schwartz C, Matthey B, Hansen H, Schindler J, Ghetie V, Vitetta ES, Diehl V, Engert A. Schnell R, et al. Among authors: borchmann p. Clin Cancer Res. 2002 Jun;8(6):1779-86. Clin Cancer Res. 2002. PMID: 12060617 Clinical Trial.

10

Current strategies of antibody-based treatment in Hodgkin's disease.

Schnell R, Borchmann P, Schulz H, Engert A. Schnell R, et al. Among authors: borchmann p. Ann Oncol. 2002;13 Suppl 1:57-66. doi: 10.1093/annonc/13.s1.57. Ann Oncol. 2002. PMID: 12078905 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters